La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Laminar Specific Detection of APP induced Neurodegeneration and Recovery using MEMRI in an Olfactory based Alzheimer’s Disease Mouse Model

Identifieur interne : 000663 ( Main/Exploration ); précédent : 000662; suivant : 000664

Laminar Specific Detection of APP induced Neurodegeneration and Recovery using MEMRI in an Olfactory based Alzheimer’s Disease Mouse Model

Auteurs : Galit Saar [États-Unis] ; Ning Cheng [États-Unis, Canada] ; Leonardo Belluscio [États-Unis] ; Alan P. Koretsky [États-Unis]

Source :

RBID : PMC:4732579

Abstract

Manganese Enhanced MRI (MEMRI) was used to detect specific laminar changes in the olfactory bulb (OB) to follow the progression of amyloid precursor protein (APP)-induced neuronal pathology and its recovery in a reversible olfactory based Alzheimer’s disease (AD) mouse model. Olfactory dysfunction is an early symptom of AD, which suggests that olfactory sensory neurons (OSNs) may be more sensitive to AD related factors than neurons in other brain areas. Previously a transgenic mouse model was established that causes degeneration of OSNs by overexpressing humanized APP (hAPP), which results in a disruption of olfactory circuitry with changes in glomerular structure. In the present work, OB volume and manganese enhancement of the glomerular layer in OB were decreased in mutant mice. Turning off APP overexpression with doxycycline produced a significant increase in manganese enhancement of the glomerular layer after only 1 week, and further recovery after 3 weeks, while treatment with Aβ antibody produced modest improvement with MRI measurements. Thus, MEMRI enables a direct tracking of laminar specific neurodegeneration through a non-invasive in vivo measurement. The use of MRI will enable assessment of the ability of different pharmacological reagents to block olfactory neuronal loss and can serve as a unique in vivo screening tool to both identify potential therapeutics and test their efficacy.


Url:
DOI: 10.1016/j.neuroimage.2015.05.045
PubMed: 26021215
PubMed Central: 4732579


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Laminar Specific Detection of APP induced Neurodegeneration and Recovery using MEMRI in an Olfactory based Alzheimer’s Disease Mouse Model</title>
<author>
<name sortKey="Saar, Galit" sort="Saar, Galit" uniqKey="Saar G" first="Galit" last="Saar">Galit Saar</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cheng, Ning" sort="Cheng, Ning" uniqKey="Cheng N" first="Ning" last="Cheng">Ning Cheng</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:aff id="A3">Alberta Children’s Hospital Research Institute (ACHRI), Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Alberta Children’s Hospital Research Institute (ACHRI), Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName>
<settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Belluscio, Leonardo" sort="Belluscio, Leonardo" uniqKey="Belluscio L" first="Leonardo" last="Belluscio">Leonardo Belluscio</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Koretsky, Alan P" sort="Koretsky, Alan P" uniqKey="Koretsky A" first="Alan P." last="Koretsky">Alan P. Koretsky</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">26021215</idno>
<idno type="pmc">4732579</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732579</idno>
<idno type="RBID">PMC:4732579</idno>
<idno type="doi">10.1016/j.neuroimage.2015.05.045</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000865</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000865</idno>
<idno type="wicri:Area/Pmc/Curation">000865</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000865</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000273</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000273</idno>
<idno type="wicri:Area/Ncbi/Merge">001B83</idno>
<idno type="wicri:Area/Ncbi/Curation">001B83</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001B83</idno>
<idno type="wicri:doubleKey">1053-8119:2015:Saar G:laminar:specific:detection</idno>
<idno type="wicri:Area/Main/Merge">000664</idno>
<idno type="wicri:Area/Main/Curation">000663</idno>
<idno type="wicri:Area/Main/Exploration">000663</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Laminar Specific Detection of APP induced Neurodegeneration and Recovery using MEMRI in an Olfactory based Alzheimer’s Disease Mouse Model</title>
<author>
<name sortKey="Saar, Galit" sort="Saar, Galit" uniqKey="Saar G" first="Galit" last="Saar">Galit Saar</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cheng, Ning" sort="Cheng, Ning" uniqKey="Cheng N" first="Ning" last="Cheng">Ning Cheng</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:aff id="A3">Alberta Children’s Hospital Research Institute (ACHRI), Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Alberta Children’s Hospital Research Institute (ACHRI), Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName>
<settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Belluscio, Leonardo" sort="Belluscio, Leonardo" uniqKey="Belluscio L" first="Leonardo" last="Belluscio">Leonardo Belluscio</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Developmental Neuronal Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Koretsky, Alan P" sort="Koretsky, Alan P" uniqKey="Koretsky A" first="Alan P." last="Koretsky">Alan P. Koretsky</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea>
<wicri:noRegion>MD 20892</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">NeuroImage</title>
<idno type="ISSN">1053-8119</idno>
<idno type="eISSN">1095-9572</idno>
<imprint>
<date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P2">Manganese Enhanced MRI (MEMRI) was used to detect specific laminar changes in the olfactory bulb (OB) to follow the progression of amyloid precursor protein (APP)-induced neuronal pathology and its recovery in a reversible olfactory based Alzheimer’s disease (AD) mouse model. Olfactory dysfunction is an early symptom of AD, which suggests that olfactory sensory neurons (OSNs) may be more sensitive to AD related factors than neurons in other brain areas. Previously a transgenic mouse model was established that causes degeneration of OSNs by overexpressing humanized APP (hAPP), which results in a disruption of olfactory circuitry with changes in glomerular structure. In the present work, OB volume and manganese enhancement of the glomerular layer in OB were decreased in mutant mice. Turning off APP overexpression with doxycycline produced a significant increase in manganese enhancement of the glomerular layer after only 1 week, and further recovery after 3 weeks, while treatment with Aβ antibody produced modest improvement with MRI measurements. Thus, MEMRI enables a direct tracking of laminar specific neurodegeneration through a non-invasive
<italic>in vivo</italic>
measurement. The use of MRI will enable assessment of the ability of different pharmacological reagents to block olfactory neuronal loss and can serve as a unique
<italic>in vivo</italic>
screening tool to both identify potential therapeutics and test their efficacy.</p>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>États-Unis</li>
</country>
<region>
<li>Alberta</li>
</region>
<settlement>
<li>Calgary</li>
</settlement>
<orgName>
<li>Université de Calgary</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Saar, Galit" sort="Saar, Galit" uniqKey="Saar G" first="Galit" last="Saar">Galit Saar</name>
</noRegion>
<name sortKey="Belluscio, Leonardo" sort="Belluscio, Leonardo" uniqKey="Belluscio L" first="Leonardo" last="Belluscio">Leonardo Belluscio</name>
<name sortKey="Cheng, Ning" sort="Cheng, Ning" uniqKey="Cheng N" first="Ning" last="Cheng">Ning Cheng</name>
<name sortKey="Koretsky, Alan P" sort="Koretsky, Alan P" uniqKey="Koretsky A" first="Alan P." last="Koretsky">Alan P. Koretsky</name>
</country>
<country name="Canada">
<region name="Alberta">
<name sortKey="Cheng, Ning" sort="Cheng, Ning" uniqKey="Cheng N" first="Ning" last="Cheng">Ning Cheng</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000663 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000663 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4732579
   |texte=   Laminar Specific Detection of APP induced Neurodegeneration and Recovery using MEMRI in an Olfactory based Alzheimer’s Disease Mouse Model
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26021215" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022